Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. KESTINE FILM-COATED TABLET 20MG [SIN15644P]

KESTINE FILM-COATED TABLET 20MG [SIN15644P]

Active ingredients: KESTINE FILM-COATED TABLET 20MG

Last updated 26 October 2025

Product Info

KESTINE FILM-COATED TABLET 20MG

[SIN15644P]

Product information

Active Ingredient and Strength

MICRONISED EBASTINE - 20 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

INDUSTRIAS FARMACEUTICAS ALMIRALL. S.A. (IFA) - SPAIN

Registration Number

SIN15644P

Licence Holder

EURODRUG LABORATORIES SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

R06AX22

INDICATION:
EBASTINE (Kestine®) is indicated in the treatment of allergic rhinitis (seasonal and perennial) with or without allergic conjunctivitis.

DOSAGE AND ADMINISTRATION:
For oral use. EBASTINE (Kestine®) 20 mg film-coated tablets may be taken with or without food. Tablets must be swallowed whole with a small amount of water.

Table caption

Adults and children over 12 years of age

– The usual dose is 10 mg of ebastine once daily, but some patients may require a dose of 20mg once daily.

Children 12 years old and below

– The safety of ebastine film-coated tablets has not been established for children under 12 years of age.

For Elderly

– not necessary to adjust dose.

For patients with Renal Impairment

– not necessary to adjust dose.

For patients with Liver Impairment

– not necessary to adjust dose but in patients with liver failure a dose of 10 mg/day should not be exceeded.

CONTRAINDICATION:
Hypersensitivity to EBASTINE or any of the excipients.